LyophilisedCAG
Cagrilintide
Bulk≥99.5% Purity
Pharmaceutical-grade cagrilintide for amylin-based weight management protocols.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Cagrilintide is a long-acting acylated amylin analogue. It activates amylin receptors (AMY1 and AMY3) in the area postrema and hypothalamus to reduce appetite, slow gastric emptying, and inhibit glucagon secretion. Its extended half-life enables once-weekly subcutaneous dosing.
Clinical Benefits
- Amylin receptor agonism for appetite reduction
- Once-weekly dosing convenience
- Complementary mechanism to GLP-1 agonists
- Supports comprehensive weight management protocols
Specifications
MechanismLong-acting amylin analogue
TargetAMY1/AMY3 receptors
Purity≥99.5%
Storage & Handling
- Store at 2–8°C
- Protect from light
Related Products
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.